Case Comprehensive Cancer Center
May 15, 2020
The National Center for Regenerative Medicine and Case Comprehensive Cancer Center announce the appointment of Timothy Chan, MD, PhD, cancer biology and immunogenomics expert, as co-director of the National Center for Regenerative Medicine. Dr. Chan is also Chair and Founding Director of the…
May 01, 2020
The Case Comprehensive Cancer Center (Case CCC) extends congratulations to Ruth Keri, PhD, professor of pharmacology and Case CCC Associate Director for Basic Research on her recent election to the Board of Directors for the Endocrine Society. Dr. Keri will serve a three-year term for the society…
May 01, 2020
The Case Comprehensive Cancer Center extends congratulations to undergraduate Jack Kincaid on receiving first prize in the 2020 Michelson-Morley Research Competition in the Biological Sciences. Jack works in the lab of member Nathan Berger, MD, sponsored by the National Cancer Institute R25…
May 01, 2020
A study led by Justin D. Lathia, PhD (Bayik et al., Cancer Discovery, 2020) and conducted in collaboration with multiple Case Comprehensive Cancer Center member investigators (Ahmad M. Khalil, PhD; Tae Hyun Hwang, PhD; Manmeet S. Ahluwalia, MD and Feixiong Cheng, PhD) identified sex differences in…
May 01, 2020
A medical device based on technology developed by three faculty members from Case Western Reserve University and University Hospitals Cleveland Medical Center (UH) has won a prestigious 2020 Edison Best New Product Award. EsoCheck, a device designed to help detect precancerous changes in the…
April 24, 2020
J. Alan Diehl has been appointed deputy director and chief operating officer of the Case Comprehensive Cancer Center, a collaboration of Case Western Reserve University, Cleveland Clinic and University Hospitals. This newly created role will provide substantive oversight of the cancer center to…
April 24, 2020
J. Alan Diehl has been appointed deputy director and chief operating officer of the Case Comprehensive Cancer Center, a collaboration of Case Western Reserve University, Cleveland Clinic and University Hospitals. This newly created role will provide substantive oversight of the cancer center to…
April 17, 2020
A study led by Nima Sharifi, MD (Hearn, Jama Oncol, 2020) found the adrenal-permissive HSD3B1 allele is associated with earlier castration resistance and shorter overall survival among men with low-volume metastatic prostate cancer. These findings lay the foundation for more personalized and…
April 17, 2020
The following is a message from the Associate Director for Clinical Research, Mitchell Machtay, MD and Deputy Associate Director for Clinical Research, Mikkael Sekeres, MD. Patients with cancer often turn to clinical trials because their other treatment options are limited. Though there has been a…
April 08, 2020
The Case Comprehensive Cancer Center has extended deadlines for a variety of open funding opportunities. Pilot project awards range from $10,000 to $180,000 and support innovative and impactful proposals that will generate key data for nationally competitive grants. View all open funding…